NervGen Ptb Ratio from 2010 to 2024

Stocks . Canada . 
Stock . NervGen Pharma Corp
NGEN Stock  CAD 2.79  0.01  0.36%   
NervGen Pharma PTB Ratio yearly trend continues to be fairly stable with very little volatility. PTB Ratio will likely drop to -83.66 in 2024. PTB Ratio is price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on NervGen Pharma's equity relative to its net asset value. View All Fundamentals
 
PTB Ratio  
First Reported
2010-12-31
Previous Quarter
(79.68)
Current Value
(83.66)
Quarterly Volatility
2.1 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check NervGen Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NervGen Pharma's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 4.9 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. NervGen financial statements analysis is a perfect complement when working with NervGen Pharma Valuation or Volatility modules.
  
This module can also supplement various NervGen Pharma Technical models . Check out the analysis of NervGen Pharma Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for NervGen Stock Analysis

When running NervGen Pharma's price analysis, check to measure NervGen Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NervGen Pharma is operating at the current time. Most of NervGen Pharma's value examination focuses on studying past and present price action to predict the probability of NervGen Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NervGen Pharma's price. Additionally, you may evaluate how the addition of NervGen Pharma to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY